_id
69171d093c536f8df23166d1
Ticker
TEM
Name
Tempus AI, Inc. Class A Common Stock
Exchange
NASDAQ
Address
600 West Chicago Avenue, Chicago, IL, United States, 60654
Country
USA
Sector
Healthcare
Industry
Health Information Services
Currency
USD
Website
https://www.tempus.com
Description
Tempus AI, Inc. operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company offers Insights, a license library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services to analytic and cloud-and-compute tools to pharmaceutical and biotechnology companies; and Trials that provides clinical trial matching services to pharmaceutical companies. In addition, it operates Next; Algos, a suite of algorithmic tests in oncology; Hub, a desktop and mobile platform for ordering, managing, and receiving tests and patient results; and Lens, a platform for researchers and scientists to find, access, and analyze Tempus data. The company has a strategic collaboration agreement with AstraZeneca and Pathos AI, Inc. to develop therapeutic programs in oncology, as well as strategic collaboration with Personalis, Inc. and Whitehawk Therapeutics, Inc. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc. in January 2023. Tempus AI, Inc. was incorporated in 2015 and is headquartered in Chicago, Illinois.
Last Close
66.37
Volume
6462903
Current Price
70.33
Change
4.84
Last Updated
2026-01-07T12:58:07.247Z
Image
data:image/webp;base64,UklGRuoAAABXRUJQVlA4IN4AAABQBwCdASpAAEAAPp1CmUmlpCKhN+gAsBOJaQAW1q6Ax/WlHy7GSwopX0bftooI1blRwClA+YnmDpO3uYWBzX6s5jjgAP7+2ZB68bKi3nS7ShAoAQXUuZEi7y9adSd9PnJUGGJPS7mH6SOCyaCG7KagdcIX+nct1a3nj35eBWTXr2cCjXVkJFPBKNnXAtTyBfoUmPHAWlTVx720U+HNCcctQC8QNh47IfHkqNlqfBHGui36Jffdhl14lDC2omQn4fwZA/48JQ/bHYN9AUJpQv/kz/Impt/LWUq6EoAAAAA=
Ipo Date
2024-06-14T00:00:00.000Z
Market Cap
12371671040
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9800705882352941
Sentiment Sources
34
Rating
3.8333
Target Price
88.9167
Strong Buy
4
Buy
2
Hold
6
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
334206000
Cost Of Revenue
128300000
Gross Profit
205906000
Operating Expenses
265850000
Operating Income
-59944000
Interest Expense
15399000
Pretax Income
-79706000
Net Income
-79982000
Eps
-0.457183686301409
Dividends Per Share
0
Shares Outstanding
172863470
Income Tax Expense
276000
EBITDA
-37276000
Operating Margin
-17.936242916045792
Total Other Income Expense Net
-19762000
Cash
655918000
Short Term Investments
103720000
Receivables
288626000
Inventories
54976000
Total Current Assets
1146511000
Property Plant Equipment
157611000
Total Assets
2281424000
Payables
59553000
Short Term Debt
12417000
Long Term Debt
1245681000
Total Liabilities
1773600000
Equity
507824000
Bs_currency_symbol
USD
Depreciation
28543000
Change In Working Capital
-71426000
Cash From Operations
-119842000
Capital Expenditures
6706000
Cash From Investing
-2309000
Cash From Financing
594690000
Net Change In Cash
472498000
Cf_currency_symbol
USD
PE
-
PB
24.228634034626168
ROE
-15.749944862787107
ROA
-3.5057928732230397
FCF
-126548000
Fcf Percent
-0.3786526872647409
Piotroski FScore
0
Health Score
8
Deep Value Investing Score
1.5
Defensive Investing Score
5
Dividend Investing Score
1
Economic Moat Investing Score
2.8
Garp Investing Score
1.5
Growth Investing Score
1.5
Momentum Investing Score
4
Net Net Investing Score
1
Quality Investing Score
1
Value Investing Score
1.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
334206000
Quarters > 0 > income Statement > cost Of Revenue
128300000
Quarters > 0 > income Statement > gross Profit
205906000
Quarters > 0 > income Statement > operating Expenses
265850000
Quarters > 0 > income Statement > operating Income
-59944000
Quarters > 0 > income Statement > interest Expense
15399000
Quarters > 0 > income Statement > pretax Income
-79706000
Quarters > 0 > income Statement > net Income
-79982000
Quarters > 0 > income Statement > eps
-0.457183686301409
Quarters > 0 > income Statement > dividends Per Share
0
Quarters > 0 > income Statement > shares Outstanding
174945000
Quarters > 0 > income Statement > income Tax Expense
276000
Quarters > 0 > income Statement > EBITDA
-37276000
Quarters > 0 > income Statement > operating Margin
-17.936242916045792
Quarters > 0 > income Statement > total Other Income Expense Net
-19762000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
655918000
Quarters > 0 > balance Sheet > short Term Investments
103720000
Quarters > 0 > balance Sheet > receivables
288626000
Quarters > 0 > balance Sheet > inventories
54976000
Quarters > 0 > balance Sheet > total Current Assets
1146511000
Quarters > 0 > balance Sheet > property Plant Equipment
157611000
Quarters > 0 > balance Sheet > total Assets
2281424000
Quarters > 0 > balance Sheet > payables
59553000
Quarters > 0 > balance Sheet > short Term Debt
12417000
Quarters > 0 > balance Sheet > long Term Debt
1245681000
Quarters > 0 > balance Sheet > total Liabilities
1773600000
Quarters > 0 > balance Sheet > equity
507824000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-79982000
Quarters > 0 > cash Flow > depreciation
28543000
Quarters > 0 > cash Flow > change In Working Capital
-71426000
Quarters > 0 > cash Flow > cash From Operations
-119842000
Quarters > 0 > cash Flow > capital Expenditures
6706000
Quarters > 0 > cash Flow > cash From Investing
-2309000
Quarters > 0 > cash Flow > cash From Financing
594690000
Quarters > 0 > cash Flow > net Change In Cash
472498000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.457183686301409
Quarters > 0 > ratios > PB
24.228634034626168
Quarters > 0 > ratios > ROE
-15.749944862787107
Quarters > 0 > ratios > ROA
-3.5057928732230397
Quarters > 0 > ratios > FCF
-126548000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-0.3786526872647409
Quarters > 0 > health Score
8
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
314635000
Quarters > 1 > income Statement > cost Of Revenue
119596000
Quarters > 1 > income Statement > gross Profit
195039000
Quarters > 1 > income Statement > operating Expenses
256813000
Quarters > 1 > income Statement > operating Income
-61774000
Quarters > 1 > income Statement > interest Expense
21579000
Quarters > 1 > income Statement > pretax Income
-42631000
Quarters > 1 > income Statement > net Income
-42843000
Quarters > 1 > income Statement > eps
-0.24710320046602569
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
173381000
Quarters > 1 > income Statement > income Tax Expense
212000
Quarters > 1 > income Statement > EBITDA
9080000
Quarters > 1 > income Statement > operating Margin
-19.633543629920382
Quarters > 1 > income Statement > total Other Income Expense Net
19143000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
186310000
Quarters > 1 > balance Sheet > short Term Investments
104996000
Quarters > 1 > balance Sheet > receivables
268819000
Quarters > 1 > balance Sheet > inventories
47600000
Quarters > 1 > balance Sheet > total Current Assets
644201000
Quarters > 1 > balance Sheet > property Plant Equipment
131214000
Quarters > 1 > balance Sheet > total Assets
1625365000
Quarters > 1 > balance Sheet > payables
79323000
Quarters > 1 > balance Sheet > short Term Debt
9381000
Quarters > 1 > balance Sheet > long Term Debt
798005000
Quarters > 1 > balance Sheet > total Liabilities
1315803000
Quarters > 1 > balance Sheet > equity
309562000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-42843000
Quarters > 1 > cash Flow > depreciation
28032000
Quarters > 1 > cash Flow > change In Working Capital
64646000
Quarters > 1 > cash Flow > cash From Operations
44164000
Quarters > 1 > cash Flow > capital Expenditures
9511000
Quarters > 1 > cash Flow > cash From Investing
-9511000
Quarters > 1 > cash Flow > cash From Financing
-293042000
Quarters > 1 > cash Flow > net Change In Cash
34725000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.24710320046602569
Quarters > 1 > ratios > PB
39.390770604919204
Quarters > 1 > ratios > ROE
-13.839876987485544
Quarters > 1 > ratios > ROA
-2.635900243945206
Quarters > 1 > ratios > FCF
34653000
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
0.1101371430387592
Quarters > 1 > health Score
19
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
255737000
Quarters > 2 > income Statement > cost Of Revenue
100534000
Quarters > 2 > income Statement > gross Profit
155203000
Quarters > 2 > income Statement > operating Expenses
223892000
Quarters > 2 > income Statement > operating Income
-68689000
Quarters > 2 > income Statement > interest Expense
18003000
Quarters > 2 > income Statement > pretax Income
-114217000
Quarters > 2 > income Statement > net Income
-68037000
Quarters > 2 > income Statement > eps
-0.39902994616025245
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
170506000
Quarters > 2 > income Statement > income Tax Expense
-46180000
Quarters > 2 > income Statement > EBITDA
-73978000
Quarters > 2 > income Statement > operating Margin
-26.85923429147914
Quarters > 2 > income Statement > total Other Income Expense Net
-45528000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
151603000
Quarters > 2 > balance Sheet > short Term Investments
67183000
Quarters > 2 > balance Sheet > receivables
262613000
Quarters > 2 > balance Sheet > inventories
50485000
Quarters > 2 > balance Sheet > total Current Assets
573970000
Quarters > 2 > balance Sheet > property Plant Equipment
133162000
Quarters > 2 > balance Sheet > total Assets
1543137000
Quarters > 2 > balance Sheet > payables
88732000
Quarters > 2 > balance Sheet > short Term Debt
9420000
Quarters > 2 > balance Sheet > long Term Debt
800764000
Quarters > 2 > balance Sheet > total Liabilities
1216943000
Quarters > 2 > balance Sheet > equity
326194000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-68037000
Quarters > 2 > cash Flow > depreciation
20353000
Quarters > 2 > cash Flow > change In Working Capital
-75076000
Quarters > 2 > cash Flow > cash From Operations
-105624000
Quarters > 2 > cash Flow > capital Expenditures
3372000
Quarters > 2 > cash Flow > cash From Investing
-375818000
Quarters > 2 > cash Flow > cash From Financing
293042000
Quarters > 2 > cash Flow > net Change In Cash
-188509000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.39902994616025245
Quarters > 2 > ratios > PB
36.762438855405065
Quarters > 2 > ratios > ROE
-20.85783306866466
Quarters > 2 > ratios > ROA
-4.409005810890414
Quarters > 2 > ratios > FCF
-108996000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-0.4262034824839581
Quarters > 2 > health Score
8
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
200680000
Quarters > 3 > income Statement > cost Of Revenue
78616000
Quarters > 3 > income Statement > gross Profit
122064000
Quarters > 3 > income Statement > operating Expenses
172764000
Quarters > 3 > income Statement > operating Income
-50700000
Quarters > 3 > income Statement > interest Expense
13359000
Quarters > 3 > income Statement > pretax Income
-12892000
Quarters > 3 > income Statement > net Income
-13014000
Quarters > 3 > income Statement > eps
-0.08027349439841329
Quarters > 3 > income Statement > dividends Per Share
5625000
Quarters > 3 > income Statement > shares Outstanding
162120761
Quarters > 3 > income Statement > income Tax Expense
122000
Quarters > 3 > income Statement > EBITDA
12460000
Quarters > 3 > income Statement > operating Margin
-25.264102053019734
Quarters > 3 > income Statement > total Other Income Expense Net
37808000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
340954000
Quarters > 3 > balance Sheet > short Term Investments
107309000
Quarters > 3 > balance Sheet > receivables
154819000
Quarters > 3 > balance Sheet > inventories
38386000
Quarters > 3 > balance Sheet > total Current Assets
667603000
Quarters > 3 > balance Sheet > property Plant Equipment
72818000
Quarters > 3 > balance Sheet > total Assets
926116000
Quarters > 3 > balance Sheet > payables
53804000
Quarters > 3 > balance Sheet > short Term Debt
6459000
Quarters > 3 > balance Sheet > long Term Debt
435436000
Quarters > 3 > balance Sheet > total Liabilities
869777000
Quarters > 3 > balance Sheet > equity
56339000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-13014000
Quarters > 3 > cash Flow > depreciation
9457000
Quarters > 3 > cash Flow > change In Working Capital
-6083000
Quarters > 3 > cash Flow > cash From Operations
-39251000
Quarters > 3 > cash Flow > capital Expenditures
7962000
Quarters > 3 > cash Flow > cash From Investing
-7962000
Quarters > 3 > cash Flow > cash From Financing
-179000
Quarters > 3 > cash Flow > net Change In Cash
-47043000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.08027349439841329
Quarters > 3 > ratios > PB
202.38117682475726
Quarters > 3 > ratios > ROE
-23.09945153446103
Quarters > 3 > ratios > ROA
-1.4052235357125888
Quarters > 3 > ratios > FCF
-47213000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-0.23526509866454057
Quarters > 3 > health Score
8
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
693398000
Annuals > 0 > income Statement > cost Of Revenue
312285000
Annuals > 0 > income Statement > gross Profit
381113000
Annuals > 0 > income Statement > operating Expenses
1072195000
Annuals > 0 > income Statement > operating Income
-691082000
Annuals > 0 > income Statement > interest Expense
53653000
Annuals > 0 > income Statement > pretax Income
-705543000
Annuals > 0 > income Statement > net Income
-705809000
Annuals > 0 > income Statement > eps
-4.353600338700606
Annuals > 0 > income Statement > dividends Per Share
5625000
Annuals > 0 > income Statement > shares Outstanding
162120761
Annuals > 0 > income Statement > income Tax Expense
266000
Annuals > 0 > income Statement > EBITDA
-610417000
Annuals > 0 > income Statement > operating Margin
-99.66599269106632
Annuals > 0 > income Statement > total Other Income Expense Net
-14461000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
340954000
Annuals > 0 > balance Sheet > short Term Investments
107309000
Annuals > 0 > balance Sheet > receivables
154819000
Annuals > 0 > balance Sheet > inventories
38386000
Annuals > 0 > balance Sheet > total Current Assets
667603000
Annuals > 0 > balance Sheet > property Plant Equipment
72818000
Annuals > 0 > balance Sheet > total Assets
926116000
Annuals > 0 > balance Sheet > payables
53804000
Annuals > 0 > balance Sheet > short Term Debt
6459000
Annuals > 0 > balance Sheet > long Term Debt
435436000
Annuals > 0 > balance Sheet > total Liabilities
869777000
Annuals > 0 > balance Sheet > equity
56339000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-705809000
Annuals > 0 > cash Flow > depreciation
37245000
Annuals > 0 > cash Flow > change In Working Capital
-37803000
Annuals > 0 > cash Flow > cash From Operations
-189045000
Annuals > 0 > cash Flow > capital Expenditures
22121000
Annuals > 0 > cash Flow > cash From Investing
-130392000
Annuals > 0 > cash Flow > cash From Financing
494329000
Annuals > 0 > cash Flow > net Change In Cash
175228000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-4.353600338700606
Annuals > 0 > ratios > PB
200.10787766804526
Annuals > 0 > ratios > ROE
-1252.7893643834643
Annuals > 0 > ratios > ROA
-76.21172725662876
Annuals > 0 > ratios > FCF
-211166000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-0.30453794213424323
Annuals > 0 > health Score
8
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
531822000
Annuals > 1 > income Statement > cost Of Revenue
245647000
Annuals > 1 > income Statement > gross Profit
286175000
Annuals > 1 > income Statement > operating Expenses
482258000
Annuals > 1 > income Statement > operating Income
-196083000
Annuals > 1 > income Statement > interest Expense
46869000
Annuals > 1 > income Statement > pretax Income
-213830000
Annuals > 1 > income Statement > net Income
-214118000
Annuals > 1 > income Statement > eps
-1.3888142434258666
Annuals > 1 > income Statement > dividends Per Share
5625000
Annuals > 1 > income Statement > shares Outstanding
154173246
Annuals > 1 > income Statement > income Tax Expense
288000
Annuals > 1 > income Statement > EBITDA
-133328000
Annuals > 1 > income Statement > operating Margin
-36.87004298430678
Annuals > 1 > income Statement > total Other Income Expense Net
-17747000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
165767000
Annuals > 1 > balance Sheet > short Term Investments
31807000
Annuals > 1 > balance Sheet > receivables
94462000
Annuals > 1 > balance Sheet > inventories
28845000
Annuals > 1 > balance Sheet > total Current Assets
350331000
Annuals > 1 > balance Sheet > property Plant Equipment
82211000
Annuals > 1 > balance Sheet > total Assets
564052000
Annuals > 1 > balance Sheet > payables
54421000
Annuals > 1 > balance Sheet > short Term Debt
6437000
Annuals > 1 > balance Sheet > long Term Debt
449665000
Annuals > 1 > balance Sheet > total Liabilities
1946215000
Annuals > 1 > balance Sheet > equity
-1382163000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-214118000
Annuals > 1 > cash Flow > depreciation
33332000
Annuals > 1 > cash Flow > change In Working Capital
-37837000
Annuals > 1 > cash Flow > cash From Operations
-214339000
Annuals > 1 > cash Flow > capital Expenditures
34608000
Annuals > 1 > cash Flow > cash From Investing
-40313000
Annuals > 1 > cash Flow > cash From Financing
117547000
Annuals > 1 > cash Flow > net Change In Cash
-137124000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-1.3888142434258666
Annuals > 1 > ratios > PB
-7.756832968933478
Annuals > 1 > ratios > ROE
15.491515834239522
Annuals > 1 > ratios > ROA
-37.960684475899384
Annuals > 1 > ratios > FCF
-248947000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-0.4681021093523773
Annuals > 1 > health Score
27
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
320668000
Annuals > 2 > income Statement > cost Of Revenue
190482000
Annuals > 2 > income Statement > gross Profit
130186000
Annuals > 2 > income Statement > operating Expenses
395628000
Annuals > 2 > income Statement > operating Income
-265442000
Annuals > 2 > income Statement > interest Expense
21894000
Annuals > 2 > income Statement > pretax Income
-289745000
Annuals > 2 > income Statement > net Income
-289811000
Annuals > 2 > income Statement > eps
-1.7060109685984102
Annuals > 2 > income Statement > dividends Per Share
5625000
Annuals > 2 > income Statement > shares Outstanding
169876399
Annuals > 2 > income Statement > income Tax Expense
66000
Annuals > 2 > income Statement > EBITDA
-236846000
Annuals > 2 > income Statement > operating Margin
-82.77782628762458
Annuals > 2 > income Statement > total Other Income Expense Net
-24303000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
302938000
Annuals > 2 > balance Sheet > short Term Investments
0
Annuals > 2 > balance Sheet > receivables
88684000
Annuals > 2 > balance Sheet > inventories
22282000
Annuals > 2 > balance Sheet > total Current Assets
438629000
Annuals > 2 > balance Sheet > property Plant Equipment
67786000
Annuals > 2 > balance Sheet > total Assets
631364000
Annuals > 2 > balance Sheet > payables
45987000
Annuals > 2 > balance Sheet > short Term Debt
6358000
Annuals > 2 > balance Sheet > long Term Debt
389546000
Annuals > 2 > balance Sheet > total Liabilities
1760391000
Annuals > 2 > balance Sheet > equity
-1129027000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-289811000
Annuals > 2 > cash Flow > depreciation
30410000
Annuals > 2 > cash Flow > change In Working Capital
71819000
Annuals > 2 > cash Flow > cash From Operations
-168204000
Annuals > 2 > cash Flow > capital Expenditures
18377000
Annuals > 2 > cash Flow > cash From Investing
-57939000
Annuals > 2 > cash Flow > cash From Financing
251391000
Annuals > 2 > cash Flow > net Change In Cash
25265000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-1.7060109685984102
Annuals > 2 > ratios > PB
-10.463172967927251
Annuals > 2 > ratios > ROE
25.66909383035127
Annuals > 2 > ratios > ROA
-45.90236377113678
Annuals > 2 > ratios > FCF
-186581000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-0.5818510110145072
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
257853000
Annuals > 3 > income Statement > cost Of Revenue
174209000
Annuals > 3 > income Statement > gross Profit
83644000
Annuals > 3 > income Statement > operating Expenses
327355000
Annuals > 3 > income Statement > operating Income
-243711000
Annuals > 3 > income Statement > interest Expense
15184000
Annuals > 3 > income Statement > pretax Income
-259192000
Annuals > 3 > income Statement > net Income
-259192000
Annuals > 3 > income Statement > eps
-1.525768155704784
Annuals > 3 > income Statement > dividends Per Share
5625000
Annuals > 3 > income Statement > shares Outstanding
169876399
Annuals > 3 > income Statement > income Tax Expense
604000
Annuals > 3 > income Statement > EBITDA
-219523000
Annuals > 3 > income Statement > operating Margin
-94.51547975009017
Annuals > 3 > income Statement > total Other Income Expense Net
-15481000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
277686000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
82244000
Annuals > 3 > balance Sheet > inventories
22908000
Annuals > 3 > balance Sheet > total Current Assets
403988000
Annuals > 3 > balance Sheet > property Plant Equipment
35395000
Annuals > 3 > balance Sheet > total Assets
531354000
Annuals > 3 > balance Sheet > payables
33753000
Annuals > 3 > balance Sheet > short Term Debt
419000
Annuals > 3 > balance Sheet > long Term Debt
238236000
Annuals > 3 > balance Sheet > total Liabilities
1338845000
Annuals > 3 > balance Sheet > equity
-807491000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-259192000
Annuals > 3 > cash Flow > depreciation
23881000
Annuals > 3 > cash Flow > change In Working Capital
14551000
Annuals > 3 > cash Flow > cash From Operations
-211984000
Annuals > 3 > cash Flow > capital Expenditures
11767000
Annuals > 3 > cash Flow > cash From Investing
-21724000
Annuals > 3 > cash Flow > cash From Financing
-2039000
Annuals > 3 > cash Flow > net Change In Cash
-235750000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-1.525768155704784
Annuals > 3 > ratios > PB
-14.629518826166485
Annuals > 3 > ratios > ROE
32.09843824884736
Annuals > 3 > ratios > ROA
-48.77953304200213
Annuals > 3 > ratios > FCF
-223751000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-0.8677463516034329
Annuals > 3 > health Score
30
Valuation > metrics > PE
-0.457183686301409
Valuation > metrics > PB
24.228634034626168
Valuation > final Score
20
Valuation > verdict
707.6% Overvalued
Profitability > metrics > ROE
-15.749944862787107
Profitability > metrics > ROA
-6.976121467652731
Profitability > metrics > Net Margin
-0.23931946164940188
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
3.4925485995147927
Risk > metrics > Interest Coverage
-3.89272030651341
Risk > final Score
-10
Risk > verdict
High
Liquidity > metrics > Current Ratio
15.930401556203973
Liquidity > metrics > Quick Ratio
15.166527719883284
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-5
Prev Risks > 1
-9
Prev Risks > 2
-9
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:40:55.364Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-02
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.2
Earnings History > 0 > eps Difference
0.2
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-04
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.11
Earnings History > 1 > eps Estimate
-0.18
Earnings History > 1 > eps Difference
0.07
Earnings History > 1 > surprise Percent
38.8889
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-08
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.22
Earnings History > 2 > eps Estimate
-0.25
Earnings History > 2 > eps Difference
0.03
Earnings History > 2 > surprise Percent
12
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-06
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.4
Earnings History > 3 > eps Estimate
-0.26
Earnings History > 3 > eps Difference
-0.14
Earnings History > 3 > surprise Percent
-53.8462
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-02-24
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.18
Earnings History > 4 > eps Estimate
-0.1532
Earnings History > 4 > eps Difference
-0.0268
Earnings History > 4 > surprise Percent
-17.4935
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-04
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.25
Earnings History > 5 > eps Estimate
-0.2807
Earnings History > 5 > eps Difference
0.0307
Earnings History > 5 > surprise Percent
10.9369
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-06
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.63
Earnings History > 6 > eps Estimate
-0.66
Earnings History > 6 > eps Difference
0.03
Earnings History > 6 > surprise Percent
4.5455
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-29
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
-
Earnings History > 7 > eps Actual
-0.98
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
-0.98
Earnings History > 7 > surprise Percent
-
Tempus AI, Inc. operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company offers Insights, a license library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services to analytic and cloud-and-compute tools to pharmaceutical and biotechnology companies; and Trials that provides clinical trial matching services to pharmaceutical companies. In addition, it operates Next; Algos, a suite of algorithmic tests in oncology; Hub, a desktop and mobile platform for ordering, managing, and receiving tests and patient results; and Lens, a platform for researchers and scientists to find, access, and analyze Tempus data. The company has a strategic collaboration agreement with AstraZeneca and Pathos AI, Inc. to develop therapeutic programs in oncology, as well as strategic collaboration with Personalis, Inc. and Whitehawk Therapeutics, Inc. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc. in January 2023. Tempus AI, Inc. was incorporated in 2015 and is headquartered in Chicago, Illinois.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ATempus AI (NASDAQ:TEM) Stock Price Down 4.2% - Here's What Happened MarketBeat
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$88.9167
Analyst Picks
Strong Buy
4
Buy
2
Hold
6
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Tempus AI, Inc. Class A Common Stock
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.2
Date
2025-09-30
EPS Actual
-0.11
EPS Estimate
-0.18
EPS Difference
0.07
Surprise Percent
38.8889%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.